DEUTSCHE BANK AG\ - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 15 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2021$1,0000.0%890.0%0.00%
Q2 2021$1,0000.0%89
-2.2%
0.00%
Q1 2021$1,0000.0%91
-69.7%
0.00%
Q4 2019$1,0003000.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Transform Wealth, LLC 106,245$35,0000.01%
UBS Group AG 1,546$5,0000.00%
Renaissance Technologies 34,325$115,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BREWIN DOLPHIN LTD 32$1070.00%
MORGAN STANLEY 63,017$210,0000.00%
AdvisorNet Financial, Inc 5$00.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders